|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Nov―27 |
Lymphocyte apoptosis in patients with coronavirus infection COVID-19 |
Khalit S. Khaertynov, Sergey V. Boichuk, Vladimir A. Anokhin, Aigul R. Galembikova, Arina E. Evdokimova |
2 |
[GO] |
2024―Nov―07 |
Analysis of plasma hemostasis and the role of microvesicles in the coagulation process in patients with COVID-19 |
Elena S. Gracheva, Rufina R. Abdullina, Il’shat G. Mustafin, Diana I. Abdulganieva |
3 |
[GO] |
2024―Jul―25 |
Characteristics of immunocompetent cells in the testicles of different age group patients with COVID-19 |
Grigory A. Demyashkin, Dmitry V. Boldyrev, Matvey A. Vadyukhin, Lia N. Alieva, Elmar N. Shirinov |
4 |
[GO] |
2023―Dez―06 |
Serotonin and 5-hydroxyindoleacetic acid are involved in the pathogenesis of COVID-19 in children |
Razina R. Nigmatullina, Dinara I. Sadykova, Tamara P. Makarova, Liliya R. Khusnutdinova, Eugeniya S. Slastnikova |
5 |
[GO] |
2023―Nov―03 |
Features of various options for anticoagulant therapy for a new coronavirus infection against the background of obesity |
Roman E. Kalinin, Igor A. Suchkov, Andrey B. Agapov, Vladislav O. Povarov, Nina D. Mzhavanadze |
6 |
[GO] |
2023―Nov―02 |
Effect of pharmacotherapy on the immune response in patients with COVID-19 |
Nadezhda I. Baranova, Liudmila A. Aschina, Alexandra I. Bolgova, Olga N. Lesina |
7 |
[GO] |
2023―Sep―29 |
The role of dehydration in the development of acute kidney injury in patients with COVID-19 |
Elvira R. Sakaeva, Aleksander М. Shutov, Elena V. Efremova, Mariya М. Rebrovskaya, Ekaterina S. Semenova |
8 |
[GO] |
2023―Sep―29 |
Effect of interval hypoxic therapy in the hypoxia-hyperoxia mode on the hemostatic system of patients who have suffered a new coronavirus infection COVID-19 |
Indira A. Misirova, Omari-Butta A. Tsuntaev, Madina V. Merzhoeva, Makka V. Merzhoeva, Irina Kh. Borukaeva |
9 |
[GO] |
2023―Jul―24 |
Immunocompetent cells of appendix in acute appendicitis in children with COVID-19 |
Grigory A. Demyashkin, Konstantin R. Gorokhov, Alexandr A. Pilipenko, Alexey V. Maslow, Svetlana E. Kochetkova |
10 |
[GO] |
2023―Apr―20 |
The course of chronic heart failure in patients after COVID-19 against the background of active cytomegalovirus infection |
Sergey N. Shilov, Svetlana D. Mayanskaya, Irina V. Pankova, Natalya S. Grigoreva, Inna V. Govor |
11 |
[GO] |
2023―Feb―16 |
Predictors of lethal outcomes in severe cases of a new coronavirus infection COVID-19 |
Konstantin G. Shapovalov, Galdan A. Tsydenpilov, Evgeny V. Lozovsky, Alexander A. Latyshov, Polina V. Petrova |
12 |
[GO] |
2023―Feb―01 |
Features of post-infarction chronic heart failure in patients with a new coronavirus infection COVID-19 |
Natalya M. Kalashnikova, Dmitriy N. Zaitsev, Anatoly V. Govorin, Natalya V. Mukha, Marina V. Chistyakova |
13 |
[GO] |
2023―Feb―01 |
The share of influence of factors determining the state of public health in the context of the COVID-19 pandemic |
Viktor V. Fomin, Natan G. Korshever, Sergey A. Sidelnikov, Valery V. Royuk, Vladimir A. Reshetnikov |
14 |
[GO] |
2023―Feb―01 |
Thoracic imaging tests for the diagnosis of COVID-19 (Russian Translation of Cochrane Plain Language Summary) |
- - |
15 |
[GO] |
2022―Okt―03 |
Anticoagulants for people hospitalized with COVID-19 (Russian Translation of Cochrane Plain Language Summary) |
- - - |
16 |
[GO] |
2022―Sep―29 |
Features of the population immunity to SARS-CoV-2 development in staff members of medical organizations during the spread of COVID-19 |
Marat N. Sadykov, Vasil B. Ziatdinov, Irina D. Reshetnikova, Niyaz M. Khakimov, Dmitriy V. Lopushov, Guzel Sh. Isaeva |
17 |
[GO] |
2022―Aug―15 |
Pathological manifestations of inflammatory microthrombosis in COVID-19 |
Rafael R. Khismatullin, Rozalina A. Ivaeva, Shahnoza Abdullayeva, Asia Z. Shakirova, Felix F. Khuzin, Andrei P. Kiassov, Rustem I. Litvinov |
18 |
[GO] |
2022―Aug―15 |
Breakthrough COVID-19 infection according to the infectious diseases hospital |
Milyausha Sh. Galiullina, Svetlana V. Khaliullina, Khalit S. Khaertynov, Marat R. Gataullin, Tatyana M. Martynova, Vladimir A. Anokhin |
19 |
[GO] |
2022―Aug―15 |
Practical aspects of the organization of ethical review of clinical trials in the context of the COVID-19 pandemic |
Farida T. Nezhmetdinova, Marina E. Guryleva |
20 |
[GO] |
2022―Jun―10 |
Metabolic therapy and its impact on lung respiratory function in patients with severe COVID-19 |
Alexey Yu. Yakovlev, Alexey A. Pevnev, Marina V. Dudorova, Yuri V. Ilyin, Mikhail S. Belous |
21 |
[GO] |
2022―Feb―07 |
Features of sinus rhythm restoration in patients with paroxysmal and persistent non-valvular atrial fibrillation and previous COVID-19 infection in iron-deficiency anaemia |
Marat K Valeev, Niyaz R Khasanov |
22 |
[GO] |
2021―Dez―13 |
Neurological aspects of COVID-19 |
M B Aliyeva, S S Saparbayev, D N Ayaganov, M S Kurmangazin, N M Tuychibaeva |
23 |
[GO] |
2021―Dez―13 |
Justification of treatment and possible outcomes of severe COVID-19 |
R F Khamitov, E N Andreicheva, A R Hairullina, G F Mingaleeva |
24 |
[GO] |
2021―Dez―13 |
Concomitant diseases in COVID-19 and their impact on the risks of adverse outcomes |
N V Ivanova, V S Belov, A I Samarkin, Z N Tretyakevich, V M Mikushev, Yu V Bruttan |
25 |
[GO] |
2021―Okt―15 |
Lung lesions caused by COVID-19 in comparison with bacterial pneumonia and influenza pneumonia: pathomorphological features |
R R Gainetdinov, S V Kurochkin |
26 |
[GO] |
2021―Aug―08 |
Exfoliative dermatitis as a complication of drug eruption associated with COVID-19 |
E V Faizullina, I M Khismatulina, R M Abdrakhmanov, V V Usmanov |
27 |
[GO] |
2021―Aug―08 |
Coronavirus infection and gut microbiota |
D D Safina, S R Abdulkhakov |
28 |
[GO] |
2021―Jun―10 |
A new look at the correction of COVID-19-mediated pulmonary gas exchange disorders |
I S Simutis, G A Boyarinov, M Yu Yuriev, D S Petrovsky, A I Kovalenko, K V Sapozhnikov |
29 |
[GO] |
2021―Apr―06 |
A case report of psoriasis exacerbation following COVID-19 |
D R Khaliullina, R M Abdrakhmanov |
30 |
[GO] |
2021―Apr―06 |
Quantitative and qualitative changes in blood cells associated with COVID-19 |
N G Evtugina, S S Sannikova, A D Peshkova, S I Safiullina, I A Andrianova, G R Tarasova, et al. (+3) R R Khismatullin, Sh M Abdullaeva, R I Litvinov |
31 |
[GO] |
2021―Apr―06 |
Outpatient management of endocrine conditions during the COVID-19 pandemic |
A P Ziganshina, A R Gosmanov |
32 |
[GO] |
2021―Feb―11 |
COVID-19: Political challenges for public health |
L M Mukharyamova, A R Zalyaev, E Yu Shammazova |
33 |
[GO] |
2020―Dez―14 |
Medical, social and ethical issues related to COVID-19 |
F T Nezhmetdinova, M E Guryleva |
34 |
[GO] |
2020―Dez―14 |
Distance learning opportunities during the COVID-19 epidemic |
A M Ziganshin, V A Mudrov, S F Nasyrova, V Z Galimzyanov, D A Salimonenko, A Yu Alekseeva, et al. (+2) I M Nasibulin, A G Yaschuk |
35 |
[GO] |
2020―Okt―28 |
Risk of long QT syndrome in novel coronavirus COVID-19 |
V N Oslopov, J V Oslopova, E V Hazova, K S Sergienko, A F Murzakhanova, J M Boichuk |
36 |
[GO] |
2020―Aug―12 |
Recommendations for the prevention and correction of thrombotic complications in COVID-19 |
S I Safiullina, R I Litvinov |
37 |
[GO] |
2020―Jun―15 |
Coronavirus infection and ophthalmology |
R F Akhmetshin, A A Rizvanov, S N Bulgar, Z G Kamalov, R F Gainutdinova, V A Usov |